Evidence map›Paper›PMID 33408632›Full record

ArticleFrontiers in pharmacology2020

Intestinal Epithelial Cell-Derived Extracellular Vesicles Modulate Hepatic Injury via the Gut-Liver Axis During Acute Alcohol Injury.

Arantza Lamas-Paz, Laura Morán, Jin Peng, Beatriz Salinas, Nuria López-Alcántara, Svenja Sydor, Ramiro Vilchez-Vargas, Iris Asensio, Fengjie Hao, Kang Zheng and 10 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Cyclic Nucleotide Phosphodiesterases in Alcohol Use Disorders: Involving Gut Microbiota.The international journal of neuropsychopharmacology · 2023
    Article
  12. Extracellular Vesicles as Biomarkers in Liver Disease.International journal of molecular sciences · 2022
    Review
  13. Review
  14. Review
  15. LncRNAFrontiers in oncology · 2022
    Article
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 3 countries.

Arantza Lamas-PazDepartment of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Madrid, Spain.
Laura MoránDepartment of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Madrid, Spain.
Jin PengDepartment of Hepatobiliary Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Beatriz SalinasServicio de Aparato Digestivo del Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Nuria López-AlcántaraDepartment of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Madrid, Spain.
Svenja SydorDepartment of Internal Medicine, University Hospital Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany.
Ramiro Vilchez-VargasDepartment of Gastroenterology, Hepatology, and Infectious Diseases, Otto von Guericke University Hospital Magdeburg, Magdeburg, Germany.
Iris AsensioServicio de Aparato Digestivo del Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Fengjie HaoDepartment of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Madrid, Spain.
Kang ZhengDepartment of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Madrid, Spain.
Beatriz Martín-AdradosDepartment of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Madrid, Spain.
Laura MorenoDepartment of Internal Medicine, University Hospital Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany.
Angel CogolludoDepartment of Internal Medicine, University Hospital Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany.
Manuel Gómez Del Moral12 de Octubre Health Research Institute (imas12), Madrid, Spain.
Lars BechmannDepartment of Internal Medicine, University Hospital Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany.
Eduardo Martínez-NavesDepartment of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Madrid, Spain.
Javier VaqueroServicio de Aparato Digestivo del Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Rafael BañaresServicio de Aparato Digestivo del Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Yulia A NevzorovaDepartment of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Madrid, Spain.
Francisco Javier CuberoDepartment of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Madrid, Spain.
Universidad Complutense de Madrid · ESResearch Institute Hospital 12 de Octubre · ESCentre for Biomedical Network Research on Rare Diseases · ESUniversitätsklinikum Knappschaftskrankenhaus Bochum · DEHospital General Universitario Gregorio Marañón · ESNanjing Drum Tower Hospital · CNRuhr University Bochum · DESpanish National Centre for Cardiovascular Research · ESUniversity Hospital Magdeburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Binge drinking, i.e., heavy episodic drinking in a short time, has recently become an alarming societal problem with negative health impact. However, the harmful effects of acute alcohol injury in the gut-liver axis remain elusive. Hence, we focused on the physiological and pathological changes and the underlying mechanisms of experimental binge drinking in the context of the gut-liver axis. Eight-week-old mice with a C57BL/6 background received a single dose (p.o.) of ethanol (EtOH) [6 g/kg b.w.] as a preclinical model of acute alcohol injury. Controls received a single dose of PBS. Mice were sacrificed 8 h later. In parallel, HepaRGs and Caco-2 cells, human cell lines of differentiated hepatocytes and intestinal epithelial cells intestinal epithelial cells (IECs), respectively, were challenged in the presence or absence of EtOH [0-100 mM]. Extracellular vesicles (EVs) isolated by ultracentrifugation from culture media of IECs were added to hepatocyte cell cultures. Increased intestinal permeability, loss of zonula occludens-1 (ZO-1) and MUCIN-2 expression, and alterations in microbiota-increased

Indexed as

alcohol (EtOH)extracellular vesiclesgut-liver axishepatocytesintestinal epithelial cells

Identifiers

PMID33408632
PMCPMC7779758
OpenAlexW3116224927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.